{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:43:28Z","timestamp":1761803008729,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ccep.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T20:28:50Z","timestamp":1577219330000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Postprocedural Management"],"prefix":"10.1016","volume":"12","author":[{"given":"Moniek","family":"Maarse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Swaans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas V.A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccep.2019.10.002_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ccep.2019.10.002_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jcin.2014.03.003","article-title":"Impact of WATCHMAN and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model","volume":"7","author":"Kar","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.ccep.2019.10.002_bib3","first-page":"181","article-title":"Transcatheter occlusion of the left atrial appendage-experimental testing of a new Amplatzer device","volume":"76","author":"Bass","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ccep.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","article-title":"Left atrial appendage obliteration: mechanisms of healing and intracardiac integration","volume":"3","author":"Schwartz","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ccep.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/09537104.2015.1096335","article-title":"Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale\/atrium septum defect closure","volume":"27","author":"Polzin","year":"2016","journal-title":"Platelets"},{"issue":"23","key":"10.1016\/j.ccep.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A\u00a0clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9689","key":"10.1016\/j.ccep.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccep.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the WATCHMAN left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.ccep.2019.10.002_bib9","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ccep.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccep.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ccep.2019.10.002_bib12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.ccep.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure\u202f: three-month data from the EWOLUTION prospective , multicentre , monitored international WATCHMAN LAA closure registry","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.ccep.2019.10.002_bib14","doi-asserted-by":"crossref","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.ccep.2019.10.002_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","article-title":"Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN","volume":"12","author":"S\u00f8ndergaard","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.ccep.2019.10.002_bib16","first-page":"S63","article-title":"Percutaneous left atrial appendage occlusion: device thrombosis in clopidogrel non-responders","volume":"81","author":"Ketterer","year":"2018","journal-title":"Resuscitation"},{"issue":"12","key":"10.1016\/j.ccep.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.hrthm.2013.08.025","article-title":"Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience","volume":"10","author":"Chun","year":"2013","journal-title":"Heart Rhythm"},{"issue":"20","key":"10.1016\/j.ccep.2019.10.002_bib18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","article-title":"Efficacy and\u00a0safety of the novel oral anticoagulants in atrial fibrillation\u202f: a systematic review and meta-analysis of the literature","volume":"126","author":"Dentali","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: safety and efficacy","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.ccep.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"issue":"14","key":"10.1016\/j.ccep.2019.10.002_bib21","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2019.10.002_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcin.2016.11.029","article-title":"Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug","volume":"10","author":"Saw","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ccep.2019.10.002_bib23","first-page":"E216","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the WATCHMAN, the Amplatzer Cardiac Plug and the Amulet","volume":"92","author":"Lempereur","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ccep.2019.10.002_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcin.2013.02.014","article-title":"Risk factors for thrombus formation on the Amplatzer cardiac plug after left atrial appendage occlusion","volume":"6","author":"Plicht","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ccep.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/echo.13413","article-title":"Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation","volume":"34","author":"Shamim","year":"2017","journal-title":"Echocardiography"},{"issue":"2","key":"10.1016\/j.ccep.2019.10.002_bib26","first-page":"68","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial","volume":"48","author":"Mant","year":"2008","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ccep.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the WATCHMAN device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with WATCHMAN left atrial appendage closure technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccep.2019.10.002_bib28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicenter experience with the ACP","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ccep.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hrthm.2016.10.020","article-title":"Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the WATCHMAN device","volume":"14","author":"Enomoto","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2019.10.002_bib30","first-page":"100358","article-title":"Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry","volume":"23","author":"Heart","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"10.1016\/j.ccep.2019.10.002_bib31","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.ccep.2019.10.002_bib32","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2019.10.002_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drug","volume":"57","author":"Lip","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918219301303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918219301303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:39:15Z","timestamp":1761802755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918219301303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1877918219301303"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2019.10.002","relation":{},"ISSN":["1877-9182"],"issn-type":[{"type":"print","value":"1877-9182"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postprocedural Management","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}